• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Life Science Equipment

Verisante Technology Inc

+ Add to Watchlist

V3T:GR

0.112 EUR 0.011 8.94%

As of 02:02:28 ET on 04/17/2014.

Snapshot for Verisante Technology Inc (V3T)

Open: 0.111 Day's Range: 0.111 - 0.112 Volume: 0
Previous Close: 0.123 52wk Range: 0.102 - 0.371 1-Yr Rtn: -69.65%

Stock Chart for V3T

No chart data available.
  • V3T:GR 0.111
  • 1D
  • 1M
  • 1Y
0.123
Interactive V3T Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for V3T

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 9.15
Shares Outstanding (M) 81.70
30 Day Average Volume 1,583
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/30/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for V3T

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for V3T

Verisante Technology Inc. is a medical device company committed to developing systems for the early detection of cancer. The Company's initial focus is skin cancer, including basal cell carcinoma, squamous cell carcinoma, and melanoma.

Thomas BraunChairman/President/CEO/FounderAnna TrinhChief Financial Officer
More Company Profile & Key Executives for V3T

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
  • V3T News

  • Industry News

No stories found
No stories found
Advertisement
Sponsored Links
Advertisements
sec ||= nil